134 related articles for article (PubMed ID: 28736219)
1. Detection of mucous membrane pemphigoid autoantibodies by full-length BP180 enzyme-linked immunosorbent assay.
Izumi K; Nishie W; Mai Y; Ujiie H; Iwata H; Natsuga K; Shimizu H
J Dermatol Sci; 2017 Nov; 88(2):247-248. PubMed ID: 28736219
[No Abstract] [Full Text] [Related]
2. Concurrent mucous membrane pemphigoid and membranous glomerulonephritis in a patient with autoantibodies targeting the 1080 region of collagen XVII.
Stump M; Messingham KN; Fairley JA
Br J Dermatol; 2019 Oct; 181(4):835-836. PubMed ID: 30916378
[No Abstract] [Full Text] [Related]
3. Circulating bullous pemphigoid autoantibodies in the setting of negative direct immunofluorescence findings for bullous pemphigoid: A single-center retrospective review.
Wang M; Lehman JS; Camilleri MJ; Drage LA; Wieland CN
J Am Acad Dermatol; 2019 Aug; 81(2):472-479. PubMed ID: 30928465
[TBL] [Abstract][Full Text] [Related]
4. Indirect immunofluorescence in mucous membrane pemphigoid: which substrate should be used?
Maglie R; Borgi A; Caproni M; Antiga E
Br J Dermatol; 2019 May; 180(5):1266-1267. PubMed ID: 30693475
[No Abstract] [Full Text] [Related]
5. Mucous membrane pemphigoid with immunoglobulin G autoantibodies against full-length and 120-kDa ectodomain of BP180.
Choi Y; Lee SE; Fukuda S; Hashimoto T; Kim SC
J Dermatol; 2011 Feb; 38(2):169-72. PubMed ID: 21269314
[TBL] [Abstract][Full Text] [Related]
6. Brunsting-Perry cicatricial pemphigoid associated with autoantibodies to the C-terminal domain of BP180.
Daito J; Katoh N; Asai J; Ueda E; Takenaka H; Ishii N; Hashimoto T; Kishimoto S
Br J Dermatol; 2008 Sep; 159(4):984-6. PubMed ID: 18637895
[No Abstract] [Full Text] [Related]
7. Study of original B cells producing pathogenic IgG and IgA autoantibodies in anti-BP180-type mucous membrane pemphigoid.
Hayashi D; Hashimoto T; Mine M; Ishii N; Hashimoto K; Tsuchisaka A; Tsuruta D
Arch Dermatol Res; 2024 May; 316(5):169. PubMed ID: 38734797
[No Abstract] [Full Text] [Related]
8. Autoimmune blisters in the gingiva.
Sasaki R; Okamoto T
BMJ Case Rep; 2020 Sep; 13(9):. PubMed ID: 32895248
[No Abstract] [Full Text] [Related]
9. Pharyngeal obstruction due to hemorrhagic bullae in a patient with anti-BP180-type mucous membrane pemphigoid associated with acquired hemophilia A.
Seo SH; Kim JH; Hashimoto T; Ishii N; Kim SC
J Dermatol; 2019 Oct; 46(10):e375-e376. PubMed ID: 31062391
[No Abstract] [Full Text] [Related]
10. Mucous Membrane Pemphigoid Presenting With Esophageal Manifestations: A Case Series.
DeGrazia T; Eisenstadt R; Willingham FF; Feldman R
Am J Gastroenterol; 2019 Oct; 114(10):1695-1697. PubMed ID: 31498153
[No Abstract] [Full Text] [Related]
11. Native collagen XVII complex ELISA: An approach for diagnosis and monitoring of anti-integrin β4 mucous membrane pemphigoid.
Mai S; Izumi K; Itamoto S; Kurosawa S; Nagata Y; Hikichi S; Miyazawa H; Tokuchi K; Imafuku K; Yanagi T; Tsutsui M; Ujiie H
J Eur Acad Dermatol Venereol; 2024 May; 38(5):e385-e387. PubMed ID: 37908157
[No Abstract] [Full Text] [Related]
12. Pure ocular mucous membrane pemphigoid reactive with both β4 integrin and the BP180 C-terminal domain.
Solano-López G; Concha-Garzón MJ; Sánchez-Pérez J; Hirako Y; Li X; Ishii N; Hashimoto T; Daudén E
Br J Dermatol; 2015 Feb; 172(2):542-4. PubMed ID: 25059542
[No Abstract] [Full Text] [Related]
13. Mucous membrane pemphigoid with IgG autoantibodies to the 120-kDa ectodomain of type XVII collagen (BP180/linear IgA dermatosis antigen) in a patient with idiopathic thrombocytopenic purpura.
Hirakawa Y; Oiso N; Ishii N; Koga H; Tatebayashi M; Uchida S; Matsuda H; Hashimoto T; Kawada A
Acta Derm Venereol; 2015 Apr; 95(4):493-4. PubMed ID: 25178495
[No Abstract] [Full Text] [Related]
14. Brunsting-Perry-type cicatricial pemphigoid with IgG autoantibodies to LAD-1.
García-Martín P; Fraga J; Hashimoto T; García-Diez A
Br J Dermatol; 2014 Mar; 170(3):743-5. PubMed ID: 24124894
[No Abstract] [Full Text] [Related]
15. Clinical and Immunological Studies of 332 Japanese Patients Tentatively Diagnosed as Anti-BP180-type Mucous Membrane Pemphigoid: A Novel BP180 C-terminal Domain Enzyme-linked Immunosorbent Assay.
Yasukochi A; Teye K; Ishii N; Hashimoto T
Acta Derm Venereol; 2016 Aug; 96(6):762-7. PubMed ID: 26984589
[TBL] [Abstract][Full Text] [Related]
16. Integrin β4 is a major target antigen in pure ocular mucous membrane pemphigoid.
Li X; Qian H; Sogame R; Hirako Y; Tsuruta D; Ishii N; Koga H; Tsuchisaka A; Jin Z; Tsubota K; Fukumoto A; Sotozono C; Kinoshita S; Hashimoto T
Eur J Dermatol; 2016 Jun; 26(3):247-53. PubMed ID: 27193492
[TBL] [Abstract][Full Text] [Related]
17. A case of anti-BP180 type mucous membrane pemphigoid treated with intravenous immunoglobulin.
Aoki N; Nakajima K; Shiga T; Koga H; Hashimoto T; Sano S
J Dermatol; 2014 Jun; 41(6):557-9. PubMed ID: 24909219
[No Abstract] [Full Text] [Related]
18. Bullous pemphigoid antigen II (BP180) and its soluble extracellular domains are major autoantigens in mucous membrane pemphigoid: the pathogenic relevance to HLA class II alleles and disease severity.
Oyama N; Setterfield JF; Powell AM; Sakuma-Oyama Y; Albert S; Bhogal BS; Vaughan RW; Kaneko F; Challacombe SJ; Black MM
Br J Dermatol; 2006 Jan; 154(1):90-8. PubMed ID: 16403100
[TBL] [Abstract][Full Text] [Related]
19. Enzyme-linked immunosorbent assay using multimers of the 16th non-collagenous domain of the BP180 antigen for sensitive and specific detection of pemphigoid autoantibodies.
Sitaru C; Dähnrich C; Probst C; Komorowski L; Blöcker I; Schmidt E; Schlumberger W; Rose C; Stöcker W; Zillikens D
Exp Dermatol; 2007 Sep; 16(9):770-7. PubMed ID: 17697150
[TBL] [Abstract][Full Text] [Related]
20. Coexistence of pemphigus herpetiformis with IgG antibodies to desmocollin 1 and pemphigoid with IgG antibodies to BP180 C-terminal domain and laminin γ2.
Ohata C; Higashi Y; Yamagami J; Koga H; Ishii N; Kanekura T; Furumura M; Hashimoto T
JAMA Dermatol; 2013 Apr; 149(4):502-4. PubMed ID: 23715433
[No Abstract] [Full Text] [Related]
[Next] [New Search]
